Login
$KRYS
$297.90 -$7.33 (2.4%) Live

$KRYS 8-K/A SEC Filings

Filed On Filing
19 Aug 2021 8-K/A: Regulation FD Disclosure

The information under “Explanatory Note” above is incorporated into this Item 7.01 by reference.

05 Nov 2019 8-K/A: Results of Operations and Financial Condition

Alignment with FDA on GMP Commercial Manufacturing Process for KB103 (Bercolagene telserpavec, “B-VEC”)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support